Cardlytics’ Relationships With Top US Banks Is Key To Targeted Marketing Success: Analyst

Needham analyst Kyle Peterson reiterated a Buy rating on Cardlytics, Inc (NASDAQ:CDLX), raising the price target to $19 from $10.

CDLX posted 2Q23 results that came in above Street expectations on billings, revenue, and EBITDA as the operating environment is showing signs of stabilization and CDLX’s optimization and efficiency efforts begin to show up in the financials.